U.S. Stocks Rise Amid Recovery Bets, FDA Approval: Markets Wrap
- Pfizer vaccine gets full approval, boosting immunization drive
- Crude rallies on improving sentiment ahead of Jackson Hole
This article is for subscribers only.
U.S. equities rose Monday as the Covid-19 immunization drive was bolstered by U.S. regulators granting full approval for the vaccine made by Pfizer Inc. and BioNTech SE.
The S&P 500 and Nasdaq 100 rebounded from lows last week as the approval could lead to more vaccine mandates amid a surge in delta variant cases that has threatened the momentum of the global economic recovery. Mixed U.S. data Monday showed July home sales coming in higher than expected while growth at U.S. services and factories slowed to an eight-month low.